| Literature DB >> 34044870 |
Zhao Yang1, Chao Xu2, Yong-Gang Zhu2, Jun Li2, Zi-Xiang Wu2, Ji-Wei Zou2, Bao-Bao Xue2, Dan-Min Miao3, Lei Shang4, Guang-Yue Zhao5.
Abstract
OBJECTIVE: This study aimed to retrospectively analyze clinical data of a series of patients with severe open fractures of extremities (Gustilo IIIb or IIIc), who achieved a satisfactory outcome through radical orthoplastic surgery, so as to provide a reference for determining the treatment of severe open fractures of extremities.Entities:
Keywords: Masqualet; Orthoplastic; Severe open fractures; Soft tissue reconstruction
Year: 2021 PMID: 34044870 PMCID: PMC8157635 DOI: 10.1186/s13018-021-02479-2
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Case 1-1. Appearance of right leg due to a blunt injury. (A-C). Appearance of right leg after debridement (D). Radiographic examination of right tibial and fibular fractures (E). Appearance of right leg after shortening and external fixation (F-H)
Fig. 2Case1-2. The design of double flow-through ALT flaps for right leg reconstruction. Appearance of left ALT flap (A) and right ALT flap (B). Defects covered by double ALT flaps (C and D). Diagram of double flow-through ALT flap (E). The appearance of survived composite flap in the right leg at 6 months postoperation (F). X-ray examinations of tibial osteotomy lengthening (G). Appearance of the survived composite flap at 9 months follow-up (H-I)
Fig. 3Case 2. Appearance of left leg due to a bruise injury. (A). Appearance of left leg after debridement (B). Appearance of left leg after fixation (C). Appearance of right ALT flap (D). Intraoperative appearance after flap transfer (E). Radiographic examination of left tibial and fibular fractures (F). Appearance of left leg after internal fixation and bone cement filling (G). Appearance of the survived composite flap at 9 months follow-up (H-J)
Factors associated with infection
| Variable | Noninfected fractures (n = 35) (%) | Infected fractures (n = 6) (%) | |
|---|---|---|---|
| Mean age (years) (range) | 36 (8 to 65) | 48 (31 to 77) | 0.093 |
| Male gender | 25 (71.4) | 6 (100) | |
| MESS > 7 | 15 (42.9) | 6 (100) | |
| Lower limb fracture | 32 (91.4) | 5 (83.3) | 0.483 |
| Median time to first coverage (h) (IQR) | 22 (18 to 31) | 21 (15.5 to 38.75) | 0.592 |
| Immediate coverage (≤ 24) | 18 (51.4) | 4 (66.7) | 0.668 |
| Initial antibiotic timing (h) (range) | 14.7 (3 to 30) | 10.3 (4 to 20) | 0.139 |
Statistically significant analyses are highlighted in bold
Demographics and clinical details of the patients
| Age (years) | Gender△ | MESS score | Gustilo classification | AO classification | Fixation* | Flap# | Initial antibiotic timing (h) | Flap timing (h) | Secondary procedures& | Union (weeks) |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 | F | 6 | IIIB | 42B3(b), 4F2A(b) | EF | ALT | 12 | 18 | 45 | |
| 54 | M | 10 | IIIB | 43C3.3, 4F2B(b),44B3.3 | ORIF | ALT | 8 | 14 | Plate replacement 6 weeks | 52 |
| 42 | F | 7 | IIIB | 13C3.3, 2U1B1 | ORIF | ALT | 24 | 35 | Skin graft 6 weeks | 43 |
| 34 | M | 7 | IIIB | 43A3.2, 4F3A | EF | ALT | 9 | 18 | 15 | |
| 31 | M | 8 | IIIB | 42C3(j), 4F2B(b) | ORIF + Screw | ALT | 13 | 56 | EF 6 weeks | 84 |
| 44 | M | 6 | IIIB | 2R3A3.1, 2U3A2.3, 77.2.1A, 77.3.1A | ORIF | ALT | 4 | 18 | 29 | |
| 9 | F | 6 | IIIB | 43A1.2, 4F2A(c), 87.1.3C | EF + Screw | ALT | 22 | 37 | 16 | |
| 47 | M | 10 | IIIB | 42B2(b), 4F2A(b) | EF + Screw | GAS | 6 | 16 | 35 | |
| 51 | F | 11 | IIIB | 42B3(a), 4F1B(n) | EF | GAS | 20 | 30 | Skin graft 6 weeks | 35 |
| 62 | F | 10 | IIIB | 42B3(a), 4F2A(a) | EF | GAS | 12 | 18 | 39 | |
| 59 | M | 11 | IIIB | 42C3(i), 4F2A(b) | EF | SOL | 14 | 20 | Bone graft + plate replacement + flap 19 weeks | 40 |
| 32 | M | 11 | IIIB | 42C2(j), 4F3A | EF + Screw | ALT | 11 | 24 | Flap 12 days | 70 |
| 45 | M | 6 | IIIB | 42B2(a), 4F2A(a) | EF + Screw | GAS | 6 | 16 | 36 | |
| 41 | M | 11 | IIIC | 2R2C3(j), 2U2C3(j) | EF | ALT | 4 | 16 | Bone shortening + plate 26 weeks | 52 |
| 24 | M | 8 | IIIB | 42B2(c), 4F2A(c) | EF | ALT | 12 | 50 | Plate 9 days | 38 |
| 41 | M | 7 | IIIB | 42C3(j), 4F2B(a) | EF | SOL | 14 | 21 | 30 | |
| 42 | M | 7 | IIIB | 42C3(j), 4F2A(b) | EF | SOL | 3 | 12 | Plate 8 weeks | 32 |
| 8 | F | 6 | IIIB | 42C2(j), 4F2B(b) | EF + Screw | ALT | 24 | 39 | Plate 6 weeks | 18 |
| 39 | F | 10 | IIIB | 42C3(j), 4F2B(b) | EF + Screw + Bone shortening | F-T ALT + ALT | 26 | 29 | Bone lengthening 35 weeks | 62 |
| 17 | F | 9 | IIIB | 2U2A2(b) | EF + ORIF | ALT | 8 | 20 | 12 | |
| 32 | F | 7 | IIIB | 43B1.1 | EF | ALT | 13 | 21 | 12 | |
| 22 | M | 9 | IIIB | 42A2(a) | EF | GAS | 13 | 20 | Flap 4 weeks | 12 |
| 37 | M | 7 | IIIB | 42A3(b), 87.1.1B | EF + Screw | SOL | 18 | 27 | 32 | |
| 44 | M | 9 | IIIB | 42B2(c), 4F3B | EF + ORIF + Cement | F-T ALT | 18 | 22 | Bone graft + plate replacement 8 weeks | 22 |
| 54 | M | 11 | IIIB | 42C3(k), 4F3B, 81.1.B2, 82A2 | EF + ORIF + Screw | ALT | 20 | 33 | Bone graft 7 weeks | 55 |
| 50 | M | 10 | IIIB | 42C2(i), 42A2(b), 4F1A(n), 4F2A(b) | EF + ORIF+ Screw | GAS | 20 | 31 | Skin graft 4 weeks | 36 |
| 65 | M | 8 | IIIB | 42B2(c), 4F2A(b) | EF + ORIF + Screw | SOL | 11 | 19 | UTN + bone graft 21 weeks | 47 |
| 9 | F | 6 | IIIB | 42B2(b) | EF + ORIF | SOL | 12 | 17 | Bone graft + plate replacement 29 weeks | 42 |
| 43 | M | 9 | IIIB | 42C3(i), 4F2A(a), 87.1.1B, 87.3.2A | EF + ORIF + Screw | SOL | 30 | 42 | Amputation | - |
| 46 | M | 7 | IIIB | 42C3(j), 4F2B(b) | EF + ORIF + Screw | SOL | 18 | 26 | Bone graft + plate replacement 11 weeks | 30 |
| 33 | M | 7 | IIIB | 42C2(j), 4F2A(b) | EF + Screw | ALT | 11 | 21 | Bone graft + plate replacement 7 weeks | 23 |
| 27 | M | 6 | IIIB | 41B3.1, 42C3(j), 4F2A(a) | EF + ORIF + Cement | ALT | 12 | 28 | Bone graft + plate replacement 17 weeks | 30 |
| 24 | M | 4 | IIIB | 42C3(j), 4F2A(b) | EF + ORIF + Cement | GAS | 23 | 31 | Bone graft + plate replacement 17 weeks | 29 |
| 30 | M | 8 | IIIB | 42C3(j), 4F2B(b) | EF + ORIF + Cement+ Bone shortening | GAS | 14 | 27 | Bone graft + plate replacement 10 weeks | 18 |
| 42 | M | 7 | IIIB | 42C2(j), 4F2B(b) | EF + ORIF + Cement | SOL | 15 | 25 | Bone graft + plate replacement 7 weeks | 21 |
| 77 | M | 9 | IIIB | 32B3(c), 42B3(b) | ORIF + Screw + Cement | GAS | 6 | 18 | Skin graft 2 weeks | 50 |
| 27 | M | 6 | IIIB | 42C3(j), 4F2A(b) | EF + ORIF + Cement | SOL | 9 | 17 | Bone graft + plate replacement 7 weeks | 19 |
| 20 | M | 6 | IIIB | 41C3.3, 4F2A(a) | EF + ORIF + Screw + Cement | GAS | 11 | 19 | 23 | |
| 65 | M | 8 | IIIB | 42C3(j), 4F2A(b) | EF + ORIF + Cement | SOL | 25 | 38 | Bone graft + plate replacement 8 weeks | 32 |
| 37 | M | 9 | IIIB | 43A2.1, 44B3.1 | EF + ORIF + Screw | ALT | 7 | 41 | Skin graft 3 weeks | 33 |
| 39 | M | 7 | IIIB | 41C3.1, 42C3(j), 4F2A(a) | EF + ORIF + Screw + Cement | SOL | 20 | 33 | Bone graft + plate replacement 18 weeks | 32 |
△
*
#
&TN unreamed tibial nial
Details of the results according to the fixation device used
| Fixation device | Number | Amputation | Union time | Acute-flap infection | Chronic-fracture site infection |
|---|---|---|---|---|---|
| EF | 11 | 35 (15 to 40) | 1 | ||
| ORIF | 3 | 43 (29 to 52) | 1 | ||
| EF + ORIF | 2 | 27 (12, 42) | |||
| EF + Screw | 8 | 33.5 (19.25 to 55.5) | 1 | ||
| ORIF + Screw | 1 | 84 | 1 | ||
| EF + ORIF + Screw | 6 | 1 | 36 (31.5 to 51) | 1 | |
| ORIF + Screw + Cement | 1 | 50 | 1 | ||
| EF + ORIF + Cement | 7 | 22 (19 to 30) | |||
| EF + ORIF + Screw + Cement | 2 | 27.5 (23, 32) |
Characteristics of the soft tissue injury and coverage
| Characteristic | Number | Infection (%) |
|---|---|---|
| Main injured zone | ||
| Elbow joint | 1 | |
| Middle forearm | 2 | 1 (50%) |
| Forearm to hand | 1 | |
| Proximal leg | 3 | |
| Middle leg | 26 | 3 (11.5%) |
| Distal leg | 2 | |
| Distal leg to ankle/foot | 6 | 2 (33.3%) |
| Soft tissue defect location | ||
| Anterior | 5 | 2 (40%) |
| Interior | 4 | 1 (25%) |
| Anteromedial | 15 | 1 (6.7%) |
| Anterolateral | 4 | 2 (50%) |
| Posterior | 1 | |
| Posterolateral | 1 | |
| Extensive | 11 | |
| Flap | ||
| ALT | 19 | 5 (26.3%) |
| GAS | 10 | 1 (10%) |
| SOL | 12 | |
Details of the results related to the timing of soft-tissue cover
| Timing of cover (h) | Number | Amputation | Union time (median, IQR, weeks) | Flap infection | Deep infection |
|---|---|---|---|---|---|
| Immediate (≤ 24) | 22 | 0 | 33.5 (21.25 to 45.5) | 0 | 4 (18%) |
| Early (24-60) | 19 | 1 | 32 (27 to 39.25) | 1 (5%) | 1 (5%) |